चिन्ह | एक्सचेंज | करेंसी |
|---|
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company’s lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
प्रकार | 5 मिनट | 15 मिनट | प्रति घंटा | दैनिक | मासिक |
|---|---|---|---|---|---|
| मूविंग एवरेज | बेचना | खरीदें | खरीदें | मजबूत खरीद | खरीदें |
| तकनीकी संकेतक | बेचना | बेचना | मजबूत खरीद | मजबूत खरीद | खरीदें |
| सारांश | बेचना | तटस्थ | मजबूत खरीद | मजबूत खरीद | खरीदें |
नाम | अंतिम | उच्च | निम्न | बदलाव | बदलाव % | वॉल्यूम | समय | ||
|---|---|---|---|---|---|---|---|---|---|
| 152.50 | 153.40 | 147.35 | +4.45 | +3.01% | 72.09K | NSE | |||
| 1.45 | 1.45 | 1.40 | +0.10 | +7.41% | 459.84K | NSE | |||
| 389.50 | 391.90 | 381.85 | +0.60 | +0.15% | 2.90K | BSE | |||
| 20.90 | 20.90 | 20.90 | 0.00 | 0.00% | 0.00 | BSE | |||
| 71.50 | 72.90 | 70.80 | -0.15 | -0.21% | 346.52K | NSE | |||
| 19.60 | 19.60 | 19.60 | +1.75 | +9.80% | 1.09K | BSE | |||
| 78.75 | 80.80 | 78.05 | -0.10 | -0.13% | 116.11K | BSE | |||
| 17.70 | 18.65 | 17.55 | -0.75 | -4.07% | 567.29K | NSE | |||
| 0.70 | 0.70 | 0.70 | 0.000 | 0.00% | 0.00 | BSE | |||
| 2,418.05 | 2,452.00 | 2,380.00 | -8.95 | -0.37% | 154.82K | NSE | |||
| 1.44 | 1.57 | 1.37 | -0.04 | -2.70% | 967.73K | BSE | |||
| 3,446.90 | 3,465.00 | 3,410.00 | +36.85 | +1.08% | 3.24K | NSE | |||
| 107.75 | 109.45 | 106.30 | -0.400 | -0.37% | 6.48M | NSE | |||
| 417.60 | 422.00 | 414.00 | +2.10 | +0.51% | 17.67K | NSE | |||
| 2.50 | 2.60 | 2.50 | -0.10 | -3.85% | 8.80K | NSE |